Efficacy and Safety Study of Ingavirin ® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o.
Conditions: Influenza, Human; Acute Respiratory Infection; Viral Infection; Common Cold Interventions: Drug: Ingavirin; Drug: Placebo oral capsule Sponsors: Valenta Pharm JSC; Atlant Clinical Ltd. Completed - verified June 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials